← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2008Last known activity
Aug 10, 2022
Timeline
1990s
- Jan 1, 1997
Lung Biotechnology PBC— Founded
Drugs by trial phase (4 distinct, 12 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Communicable Diseases
- Coronaviridae Infections
- Coronavirus Infections
- Familial Primary Pulmonary Hypertension
- Fibrosis
- Hypertension
- Hypertension, Pulmonary
- Idiopathic Pulmonary Fibrosis
- Immune System Diseases
- Infections
- Lung Diseases
- Lung Diseases, Obstructive
- Nidovirales Infections
- Pneumonia
- Pneumonia, Viral
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Severe Acute Respiratory Syndrome
- Virus Diseases
Recent trials (12)
- NCT05203510CollaboratorPhase 4Aug 10, 2022
- NCT04365101CollaboratorPhase 1/Phase 2May 13, 2020
- NCT03657095Lead sponsorPhase 3Dec 31, 2018
- NCT03794583CollaboratorPhase 3Dec 21, 2018
- NCT01966302CollaboratorPhase 2Nov 1, 2013
- NCT01908699Lead sponsorPhase 3May 1, 2013
- NCT01458236Lead sponsorPhase 3Nov 1, 2011
- NCT00989963Lead sponsorPhase 2Nov 1, 2009
- NCT00990314Lead sponsorPhase 2Nov 1, 2009
- NCT00792571Lead sponsorPhase 2Feb 1, 2009
- NCT00781885Lead sponsorPhase 2Jan 1, 2009
- NCT00703339Lead sponsorPhase 2Jun 1, 2008
Details
- Founded
- Silver Spring, MD, US Jan 1, 1997
- Last known activity
- Aug 10, 2022